Dr. Leu-Wei Lo received his Ph.D. in Molecular Biophysics from the Perelman School of Medicine, University of Pennsylvania, USA in 1996 and is currently the Senior Investigator at the Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes (NHRI), Taiwan. Dr. Lo’s research interests lie primarily in the field of Translational Nanotheranostics — Illuminating Targeting Nanotherapeutics with Precision Molecular Imaging Innovations. It harnesses multidisciplinary approaches to advance biophotonic/radiological nanomedicine, especially in the design and the application of novel nanoplatforms for in vivo spectroscopy and the fusion of multimodality imaging-guided diagnostics and therapeutics in phototherapy and radiotherapy for cancers, cardiovascular diseases, central nervous system injury, and metabolic diseases, such as obesity. Dr. Leu-Wei Lo has published more than 100 referred papers, many with high citations in prestigious journals. He also holds more than 20 patents in facilitating translational nanomedicine with global deployment of industrialization. Dr. Lo was endowed as IAAM Fellow (FIAAM) by the International Association of Advanced Materials (Sweden) in 2021; he has received many awards, including the NHRI Outstanding Research Achievement Award (2016), the Future Tech (FUTEX) Award (2019), three consecutive National Innovation Awards (Taiwan) (2019-2021), and the Taipei Biotech Special Mention Award (2022).